Cargando…

Association of Elbow Flexor MRI Fat Fraction With Loss of Hand-to-Mouth Movement in Patients With Duchenne Muscular Dystrophy

BACKGROUND AND OBJECTIVES: To study the potential of quantitative MRI (qMRI) fat fraction (FF) as a biomarker in nonambulant patients with Duchenne muscular dystrophy (DMD), we assessed the additive predictive value of elbow flexor FF to age at loss of hand-to-mouth movement. METHODS: Nonambulant pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naarding, Karin J., van der Holst, Menno, van Zwet, Erik W., van de Velde, Nienke M., de Groot, Imelda J.M., Verschuuren, Jan J.G.M., Kan, Hermien E., Niks, Erik H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605612/ https://www.ncbi.nlm.nih.gov/pubmed/34493619 http://dx.doi.org/10.1212/WNL.0000000000012724

Ejemplares similares

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
por: Naarding, Karin J., et al.
Publicado: (2021)

The Black Box of Technological Outcome Measures: An Example in Duchenne Muscular Dystrophy
por: Naarding, Karin J., et al.
Publicado: (2022)

Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies
por: Veeger, Thom T. J., et al.
Publicado: (2021)

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy
por: Naarding, Karin J., et al.
Publicado: (2020)

Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy
por: Naarding, Karin J., et al.
Publicado: (2020)

Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy
por: van de Velde, Nienke M., et al.
Publicado: (2021)

Multi‐parametric MR in Becker muscular dystrophy patients
por: Hooijmans, Melissa T., et al.
Publicado: (2020)

The neurocognitive profile of adults with Becker muscular dystrophy in the Netherlands
por: Koeks, Zaıda, et al.
Publicado: (2022)

Age-Related Longitudinal Changes in Metabolic Energy Expenditure during Walking in Boys with Duchenne Muscular Dystrophy
por: Brehm, Merel-Anne, et al.
Publicado: (2014)

Clinical Management of Duchenne Muscular Dystrophy in the Netherlands: Barriers to and Proposals for the Implementation of the International Clinical Practice Guidelines
por: Heutinck, Lotte, et al.
Publicado: (2021)

Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation
por: Houwen‐van Opstal, Saskia L. S., et al.
Publicado: (2021)

Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
por: Doorenweerd, Nathalie, et al.
Publicado: (2017)

Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
por: Doorenweerd, Nathalie, et al.
Publicado: (2018)

Diffusion‐tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy
por: Cameron, Donnie, et al.
Publicado: (2023)

Baseline fat fraction is a strong predictor of disease progression in Becker muscular dystrophy
por: Veeger, Thom T. J., et al.
Publicado: (2022)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
por: Spitali, Pietro, et al.
Publicado: (2018)

Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients
por: Doorenweerd, Nathalie, et al.
Publicado: (2021)

Prevalence of Bladder and Bowel Dysfunction in Duchenne Muscular Dystrophy Using the Childhood Bladder and Bowel Dysfunction Questionnaire
por: Lionarons, Judith M., et al.
Publicado: (2021)

Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24–month follow-up
por: Hooijmans, M. T., et al.
Publicado: (2017)

Characterization of patients with Becker muscular dystrophy by histology, magnetic resonance imaging, function, and strength assessments
por: Comi, Giacomo P., et al.
Publicado: (2021)

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study
por: Comi, Giacomo P., et al.
Publicado: (2023)

Compliance to DMD Care Considerations in the Netherlands
por: Heutinck, Lotte, et al.
Publicado: (2021)

Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine(ratio), and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy
por: van de Velde, Nienke M., et al.
Publicado: (2023)

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
por: Strandberg, Kristin, et al.
Publicado: (2020)

Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers
por: Johansson, Camilla, et al.
Publicado: (2023)

Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study
por: Jansen, Merel, et al.
Publicado: (2010)

Variables associated with upper extremity function in patients with Duchenne muscular dystrophy
por: Janssen, Mariska M. H. P., et al.
Publicado: (2016)

Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature
por: de Meel, Robert H.P., et al.
Publicado: (2019)

DMD Genotypes and Motor Function in Duchenne Muscular Dystrophy: A Multi-institution Meta-analysis With Implications for Clinical Trials
por: Muntoni, Francesco, et al.
Publicado: (2023)

Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy
por: Ayyar Gupta, Vandana, et al.
Publicado: (2023)

Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)

Compliance to Care Guidelines for Duchenne Muscular Dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2015)

Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
por: Landfeldt, Erik
Publicado: (2018)

Elbow Common Flexor Tendon Repair Technique
por: Alrabaa, Rami George, et al.
Publicado: (2019)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
por: Signorelli, Mirko, et al.
Publicado: (2019)

Characterization of pulmonary function in Duchenne Muscular Dystrophy
por: Mayer, O.H., et al.
Publicado: (2015)

Surface EMG signals in very late-stage of Duchenne muscular dystrophy: a case study
por: Lobo-Prat, Joan, et al.
Publicado: (2017)

The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy
por: Keene, Kevin R., et al.
Publicado: (2020)

Molecular Analysis and Diagnosis of Duchenne Muscular Dystrophy
por: Forrest, S. M., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_ptpvr5mj33s145s21i792m5v20